My Watchlist for Tuesday, December 27
( click to enlarge )
Conatus Pharmaceuticals Inc (NASDAQ:CNAT) has been consolidating its gap up in a bull flag formation on hourly chart, and on Friday the stock broke out of that flag and is approaching previous high at around 4.50, which if broken, could lead the way to a re-testing of $5.50. Analysts are very bullish on this stock, with price targets well above current levels, which can serve as a catalyst for a pop in the share price. Last week SunTrust Robinson Humphrey reiterated a Buy rating on Conatus Pharmaceuticals and raised its price target to $26.00. If momentum continues, the stock could break the resistance level of $5.50 and move higher.
( click to enlarge )
IntelliPharmaCeutics Intl Inc (NASDAQ:IPCI) is consolidating in a large ascending triangle beneath resistance at 3.35, that has contained prices on 2 occasions over the last three months. On Friday, we finally broke the minor resistance of 2.95 on a higher then average volume and now we are going to the top of the consolation pattern. A break through current resistance level at 3.35 area could lead to 4.1 zone on the medium-term.
( click to enlarge )
Microvision, Inc. (NASDAQ:MVIS) has been under pressure recently but in the last sessions the stock reversed its trend. The daily indicators are also showing signs of reversal. If it can break through the 1.30 resistance level, the stock should have a nice move on the upside.
( click to enlarge )
Im keeping Dataram Corp (NASDAQ:DRAM) on the list for a possible move this week. The stock recently has been strong, which leads me to believe that there are buyers and we could see another up move soon. DRAM is a fast moving stock, so you need to watch it closely, because once it breaks through 1.72, it will run fast.
( click to enlarge )
ProNAi Therapeutics Inc (NASDAQ:DNAI) has been slowly creeping higher and I think it could be trading over $1.85 in the short term. DNAI still needs to take out the EMA50 at $1.55. Although the stock did not perform well this year, we finally start to see some signals of rebound as the daily technical chart shows positive momentum is back. I'd look to the $1.55 level moving as the next buy point. If it passes that, then we have room to run to next resistance at $1.85 then 2.15. Let’s keep an eye on it.
( click to enlarge )
Portola Pharmaceuticals Inc (NASDAQ:PTLA) saw its shares surged almost 34% to $25.06 per share on Friday, after the company said U.S. and European agencies accepted applications for for betrixaban. The stock has the potential to make another big run this week, but a short-term pullback would not surprise as well. As long as price does not break below $24 the outlook is very positive.
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.
Thanks for visiting AC Investor Blog.
AC
( click to enlarge )
Neovasc Inc (NASDAQ:NVCN) The strong bounce off the EMA200 and the very bullish candle looks pretty promising for longs this week. A break of 2 would confirm continuation of the upmove with a stop loss located at 1.60
If you want to contact me for advertising opportunities on blog or twitter, then get in touch via email
If you want to contact me for advertising opportunities on blog or twitter, then get in touch via email
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.
Thanks for visiting AC Investor Blog.
AC
Labels: CNAT, DNAI, DRAM, IPCI, MVIS, NVCN, PTLA
| Permalink | 
